Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2023–2024 · award
Wild-type IDH1 programs the immune response to pancreatic cancer
Jordan Winter · University Hospitals Cleveland Medical Center
2023–2024 · award
Yale Cancer Center/ACS- Diversity in Cancer Research Program
2023–2027 · award
Targeting YAP1 in RAS-driven Neuroblastoma
2023–2027 · award
Multilevel influences that contribute to racial/ethnic disparities in receipt of guideline concordant treatment for early-stage NSCLC
Albert Farias · University Of Southern California (usc)
2023–2027 · award
T cell membrane-anchored tumor targeted Il12 (attIL12)-T cell therapy in subjects with advanced/metastatic sarcoma
John Livingston · The University of Texas MD Anderson Cancer Center
2023–2028 · award
Achieving equity in lung cancer screening
2023–2025 · award
Investigating the role of LMP1 in lipid peroxidation and ferroptosis protection
2023–2026 · award
Mechanisms of Genome Maintenance and Therapeutic Resistance via BRCA Axis
Weixing Zhao · The University of Texas at San Antonio Health Science Center
2023–2024 · award
ENCOURAGE-Diversity
2023–2026 · award
Barriers and Facilitators of Parent-Child Communication in Children with Cancer Predisposition
2023–2026 · award
Disparities Along the Care Continuum for Rural Cancer Patients
2023–2028 · award
Supporting decision-making in breast cancer with patient reported outcomes in a novel web-based decision aid
Sarah Tevis · University Of Colorado Denver, Amc And Dc
2023–2024 · award
Patient Reported Outcomes in Metastatic Prostate Cancer (PROPER)
Adanma Ayanambakkam · Board Of Regents Of The University Of Oklahoma, Health Sciences Center
2023–2027 · award
Role of Hypoxia in Shaping the Tumor Stroma in Pancreatic Cancer
2023–2025 · award
Institutional Research Grant
2023–2025 · award
Intratumoral genomic and transcriptomic heterogeneity contributes to therapeutic resistance in adrenocortical carcinoma
2023–2027 · award
Targeting a 19S Proteasome Subunit in Acute Myeloid Leukemia (AML)
2023–2025 · award
ACS/CDU Diversity in Cancer Research Internship
Jaydutt Vadgama · Charles R. Drew University of Medicine and Science
2023–2026 · award
Delineating determinants of NK-cell mediated killing of tumor cells through functional genomics
2023–2027 · award
Decoding transcriptional identity in LKB1 mutant Non-Small Cell Lung Cancer (NSCLC)
2023–2026 · award
Harnessing Systemic T Cell Responses in Breast Cancer
2023–2026 · award
Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine
2023–2024 · award
HDAC Inhibitors and “third Party” Adoptive Cell Therapeutics for the Treatment of High-Risk Neuroblastoma
2023–2027 · award
Genetic and radiomic markers to guide supplemental screening for breast cancer
2023 · award
Evaluating glioblastoma-secreted GABA’s contributions to the immunosuppressive environment and tumor growth.
Daniel Kaufman · The Regents Of The University Of California, Los Angeles
2023–2026 · award
Targeting FACT to shift the undifferentiated state of ZFTA-RelA fusion driven ependymoma
2023–2024 · award
Regulation of fibroblast plasticity in pancreatic cancer
2023–2025 · award
Exploiting senomimetic drug effects to improve immunotherapy in breast cancer
2023–2028 · award
Dissecting the immune cell interactions in the bone marrow microenvironment of chronic myelomonocytic leukemia
2023–2026 · award
The requirement for disheveled specificity in hematopoietic stem cell development
2023–2026 · award
IGFBP5 Induced Cachexia in Pancreatic Cancer
Prakash Radhakrishnan · Rutgers, The State University of New Jersey
2023–2027 · award
The SNAI2-RUNX2 signaling axis is a novel driver of osteosarcoma initiation, growth and therapy resistance
2023–2024 · award
Investigating the Organization and Dynamics of Extrachromosomal DNA Regulation in Human Cancer
2023–2024 · award
Assessment of Mastectomy-related Range of Motion Deficits via Smartphone App
2023–2025 · award
Facilitating drug discovery with synthetic antibodies against oncogenic protein complexes
2023–2024 · award
Overcoming adenosine-mediated suppression to enhance the anti-tumor efficacy of engineered T cell therapy
2023–2026 · award
Novel conceptual framework for cancer comparative effectiveness research
2023–2026 · award
Dissecting the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis for improved risk stratification and treatment
2023–2028 · award
Prevention of Infection Related Cancers
2023–2024 · award